NEW YORK (GenomeWeb) – Edico Genome said today that it raised $10 million in a Series A round of financing that it will use to commercialize its Dragen Bio-IT Processor, an application-specific integrated circuit system for next-generation sequence data analysis.

The financing round was led by Qualcomm through its venture investment group Qualcomm Ventures. The list of investors includes Axon Ventures and Greg Lucier, former Life Technologies chairman and CEO. As part of his investment, Lucier has joined Edico Genome's board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.